Tag

Manjula Ramamurthy

2 articles

Strides Posts FY26 Earnings Call Recording

• Strides Pharma notified exchanges of audio recording availability for its May 18, 2026 earnings call discussing FY26 results. • The call was held at 17:00 IST to review audited financial results for

Strides Pharma FY26 Results: Dividend, Demerger Gain

Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, along with a final dividend of ₹5 per share. Consolidated FY26 revenue rose to ₹50,094 million